[go: up one dir, main page]

FR2915378B1 - Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries - Google Patents

Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries

Info

Publication number
FR2915378B1
FR2915378B1 FR0703050A FR0703050A FR2915378B1 FR 2915378 B1 FR2915378 B1 FR 2915378B1 FR 0703050 A FR0703050 A FR 0703050A FR 0703050 A FR0703050 A FR 0703050A FR 2915378 B1 FR2915378 B1 FR 2915378B1
Authority
FR
France
Prior art keywords
soybeans
preparing
active ingredient
glycine max
composition intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0703050A
Other languages
English (en)
Other versions
FR2915378A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0703050A priority Critical patent/FR2915378B1/fr
Publication of FR2915378A1 publication Critical patent/FR2915378A1/fr
Application granted granted Critical
Publication of FR2915378B1 publication Critical patent/FR2915378B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
FR0703050A 2007-04-27 2007-04-27 Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries Expired - Fee Related FR2915378B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0703050A FR2915378B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0703050A FR2915378B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries

Publications (2)

Publication Number Publication Date
FR2915378A1 FR2915378A1 (fr) 2008-10-31
FR2915378B1 true FR2915378B1 (fr) 2009-08-21

Family

ID=38740544

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0703050A Expired - Fee Related FR2915378B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries

Country Status (1)

Country Link
FR (1) FR2915378B1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2938766B1 (fr) * 2008-11-26 2010-12-31 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur de l'aconitase et protecteur des mitochondries
FR2943542B1 (fr) * 2009-03-31 2012-05-25 Lvmh Rech Methode de soin cosmetique anti-age par stimulation de l'activite de l'aconisate mitochondriale.
FR2944018B1 (fr) 2009-04-02 2012-03-09 Isp Investments Inc Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant
FR2944017B1 (fr) 2009-04-02 2012-03-09 Isp Investments Inc Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant
FR2944795B1 (fr) * 2009-04-23 2013-08-02 Isp Investments Inc Hydrolysats peptidiques activateurs du proteasome et compositions les contenant
FR2944796B1 (fr) * 2009-04-23 2013-08-02 Isp Investments Inc Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant
FR2944798B1 (fr) 2009-04-23 2013-05-10 Isp Investments Inc Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant
FR2944797B1 (fr) 2009-04-23 2013-05-10 Isp Investments Inc Hydrolysats peptidiques activateurs du proteasome et compositions les contenant
FR2987998B1 (fr) 2012-03-19 2014-04-25 Isp Investments Inc Composition cosmetique comprenant un systeme activateur de la proteine trf2 a action synergique constitue d'une association d'un extrait peptidique de soja et de levure et ses utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
BR0203902A (pt) * 2001-02-14 2003-01-28 Matthias Rath Composições de compostos bioquìmicos envolvidos no metabolismo bioenergético das células e método de uso da mesma
FR2854069B1 (fr) * 2003-04-23 2006-03-10 Silab Sa Procede d'obtention d'un principe actif a partir du soja, ayant des proprietes anti-vieillissement, compositions et utilisations de ces compositions a visee cosmetique
EP1789107B1 (fr) * 2004-08-30 2009-05-27 Interstitial Therapeutics Endoprothese medicale pourvue d'inhibiteurs de la synthese d'atp

Also Published As

Publication number Publication date
FR2915378A1 (fr) 2008-10-31

Similar Documents

Publication Publication Date Title
FR2915378B1 (fr) Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
FR2915381B1 (fr) Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
FR2915384B1 (fr) Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
ATE394925T1 (de) Konzentrierte wässrige formulierungen für den pflanzenschutz
EP2124872A4 (fr) Compositions pour améliorer des conditions cutanées renfermant de l'alpha-bisabolol en tant que principe actif
UA116809C2 (uk) Застосування агрохімічних сумішей для збільшення життєздатності рослини
DOP2010000047A (es) Compuestos de pirazol y su uso como inhibidores de raf
FR2918893B1 (fr) Utilisation d'un principe actif issu du lin pour preparer une composition destinee a activer le cytochrome c
NI201200168A (es) Formulaciones farmacéuticas
BR112013016595A2 (pt) inibidores de neprilisina
HN2009000455A (es) Inhibidore de quinasa
CR11252A (es) Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met
IL196012A0 (en) Low-foaming preparations for crop protection
CL2007002242A1 (es) Forma de dosificacion farmaceutica oral en comprimido, capsula o granulo que comprende bis-(monoetanolamina) de acido 3'-[(2z)-[1-(3,4-dimetilfenil)-1,5-dihidro-3-metil-5-oxo-4h-pirazol-4-ilideno]hidrazino]-2'-hidroxi[1-1'-bifenil]-3-carboxilico; pro
CL2007002446A1 (es) Compuestos derivados de morfolino pirimidina; composicion farmaceutica; y su uso para preparar un medicamento para producir un efecto antiproliferante.
PL2389073T3 (pl) Wytwarzanie rozpuszczalnego produktu z białkiem sojowym, z masy miceralnej białka sojowego ("S200Ca")
MA32383B1 (fr) DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
CR10479A (es) Modulares bencimidazolicos de vr1
FR2915379B1 (fr) Utilisation d'un principe actif issu du riz (oryza sativa l) pour preparer une composition destinee a proteger les mitochondries
EA200970124A1 (ru) Производные 2-арилиндола в качестве ингибиторов npges-1
CO6612255A2 (es) Sales de 4-[2-[[5-metil-1-(2-naftalenil)-1h-pirazol-3-il]oxi]eil]morfolina
MX2007012732A (es) Derivados de azol en forma de inhibidores de lipasas y fosfolipasas.
EP2364157A4 (fr) Compositions d'extraits de plantes destinées à affecter le sommeil
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
EP2040718A4 (fr) Formulations de nitrate de gallium

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151231